Port site metastasis after robotic assisted laparoscopic radical prostatectomy: Diagnosis via prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL PET/CT
Joon Yau Leong, Maria J. D'Amico, Courtney E. Capella and 2 more
Urology Case Reports · 2025
doi:10.1016/j.eucr.2025.103082 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
We present a case of port site metastasis (PSM) that was identified in an 82-year-old man with an elevated prostate-specific antigen (PSA) to 3.9 ng/mL, concerning for biochemical recurrence after robotic-assisted radical prostatectomy, adjuvant radiation, and six months of androgen deprivation therapy with an undetectable PSA post-treatment over 10 years ago. A 2.1 cm solitary tracer avid nodule on the right lateral abdominal wall with no other evidence of recurrence or metastatic disease was found on prostate-specific membrane antigen (PSMA)–targeted 18F-DCFPyL PET/CT scan. The patient underwent local excision of this metastatic lesion, and final pathology revealed metastatic prostatic adenocarcinoma.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.